Joseph Todisco is the Chief Executive Officer at CorMedix, a biopharmaceutical company focused on developing and commercializing therapeutic products.
Joseph Todisco is the Chief Executive Officer at CorMedix, a biopharmaceutical company focused on developing and commercializing therapeutic products for infectious and inflammatory diseases. He was appointed CEO in May 2022. Previously, Mr. Todisco was a senior executive at Amneal Pharmaceuticals and co-founder of Gemini Laboratories, a specialty pharmaceutical company. He also held a role as Vice President, Business Development & Licensing at Ranbaxy, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library